Astellas Pharma Inc. is setting up a joint venture with Yaskawa Electric Corp. to develop a new cell production platform ...

Joint venture is expected to leverage Astellas' expertise in cell therapy R&D and Yaskawa’s robotics technology to enhance ...

The agreement—powered by YASKAWA's Maholo robot—aims to address challenges in production and commercialization while offering ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and YASKAWA Electric Corporation (TSE: 6506, President and CEO; Masahiro Ogawa, "YASKAWA") signed a definitive agreement ...

Astellas Pharma and the Yaskawa Electric Corporation have agreed to form a joint venture (JV) that will focus on developing a ...

TASC is our industry’s premier peer-to-peer automation stage where America’s shop leaders refine the art of metalworking and CNC machining. For conference speakers, it's also an opportunity to ...

Astellas and Yaskawa are establishing a joint venture for the development of a cell therapy product manufacturing platform ...

The planned joint venture will leverage Astellas' expertise in R&D and manufacturing for cell therapy and the dual arm robot "Maholo," developed by YASKAWA's subsidiary, Robotic Biology Institute.

Astellas Pharma Inc. is setting up a joint venture with Yaskawa Electric Corp. to develop a new cell production platform using Yaskawa’s dual-arm humanoid robot called Maholo. BioWorld BioWorld ...